氣喘墊片市場 - 按產品類型（AeroChamber、OptiChamber、Volumatic、Inspirease）、按配銷通路（零售藥房、醫院藥房、線上藥房） - 全球預測 2024 年 - 2032 年

Asthma Spacers Market - By Product Type (AeroChamber, OptiChamber, Volumatic, Inspirease), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) - Global Forecast 2024 - 2032

出版日期: 2024年03月01日 | 出版商:

Global Market Insights Inc. | 英文 75 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年至 2032 年，全球氣喘間隔器市場規模將實現 5.5% 的複合年成長率，這歸因於吸入器技術的進步和醫療保健基礎設施的擴展，以及對間隔器益處的認知的提高。現代吸入器需要相容的墊片以實現最佳藥物輸送，並增加醫療機構的使用機會，導致需求不斷成長。隨著患者和醫療保健提供者認知到墊片在提高藥物有效性方面的優勢，市場將會擴大。這些因素凸顯了氣喘間隔物產業的光明前景，可以滿足全球氣喘患者的需求。

例如，2023 年 5 月，南非過敏基金會 (AFSA) 向南非市場推出了新型間隔裝置 AfriSpacer。這項進展凸顯了為提高獲得有效氣喘治療方案所做的努力，可能會影響氣喘間隔物市場的全球趨勢和策略。

氣喘間隔物產業根據產品類型、分銷管道和地區進行分類。

零售藥局部門將在 2032 年獲得可觀的市場佔有率，這得益於零售藥局為氣喘患者購買間隔器提供的便利性和可及性。隨著全球氣喘盛行率不斷上升，零售藥局在分發這些基本設備方面發揮著至關重要的作用。它們在社區中廣泛存在，再加上獲得處方和藥劑師指導的便利性，使得零售藥局成為購買氣喘間隔器的首選。隨著對可靠且易於使用的氣喘管理解決方案的需求不斷成長，零售藥房領域將保持其在市場上的主導地位。

由於大容量氣喘墊片在有效性和用戶友善性方面享有盛譽，到 2032 年，大容量氣喘墊片的市場佔有率將獲得可觀的成長。醫療保健提供者和患者都更喜歡 Volumatic 儲霧罐，因為它具有易於使用和與各種吸入器相容等特點。隨著全球對可靠、高效的墊片的需求不斷成長，大批量的墊片市場將保持其突出地位。其在促進最佳藥物傳遞方面的記錄及其在醫療保健環境中的廣泛採用使其成為值得信賴和搶手的選擇，鞏固了其在哮喘間隔物市場中的關鍵地位。

2024 年至 2032 年間，亞太地區氣喘間隔物市場將以顯著的複合年成長率成長。隨著人口的成長和醫療保健支出的增加，對有效的氣喘管理解決方案的需求不斷增加。醫療保健組織的宣傳活動和措施也對推動市場發揮了作用。隨著亞太地區繼續優先考慮呼吸健康，其在氣喘墊片行業的主導地位將持續存在，使其成為市場擴張的主要貢獻者。

產業生態系統分析
產業影響力
- 成長動力
  - 慢性呼吸道疾病盛行率不斷上升
  - 氣喘間隔器領域的技術進步
  - 人們越來越認知到墊片的好處
  - 加大產品創新研發投入
- 產業陷阱與挑戰
  - 設備成本高
  - 對設備缺乏認知
成長潛力分析
監管環境
技術景觀
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按產品類型，2018 年 - 2032 年

主要趨勢
空氣艙
視室
體積
靈感
其他產品類型

第 6 章：市場估計與預測：按配銷通路分類，2018 年 - 2032 年

主要趨勢
醫院藥房
零售藥局
網路藥局

第 7 章：市場估計與預測：按地區分類，2018 年 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 8 章：公司簡介

Cipla Inc.
GlaxoSmithKline plc
Koninklijke Philips N.V.
Koo Medical Equipment
Laboratoire ProtecSom
Lupin Limited
Mediacare Equipments (India) Pvt. Ltd.
Monaghan Medical Corporation
PARI GmbH
Rossmax International Ltd.
Teleflex Incorporated

簡介目錄

Product Code: 8354

Global Asthma Spacers Market size will register a 5.5% CAGR from 2024 to 2032, attributed to advancements in inhaler technology and the expansion of healthcare infrastructure, coupled with heightened awareness of spacer benefits. Modern inhalers requiring compatible spacers for optimal drug delivery and increased access to healthcare facilities contribute to rising demand. As patients and healthcare providers recognize the advantages of spacers in improving medication effectiveness, the market will expand. These factors underscore a promising future for the asthma spacers industry, catering to the needs of asthma patients worldwide.

For instance, in May 2023, the Allergy Foundation of South Africa (AFSA) introduced AfriSpacer, a new spacer device, to the market in South Africa. This development highlights efforts to enhance access to effective asthma treatment options, potentially influencing global trends and strategies in the asthma spacers market.

The asthma spacers industry is classified based on product type, distribution channels, and region.

The retail pharmacies segment will secure a substantial market share by 2032, fueled by the convenience and accessibility of retail pharmacies for asthma patients to purchase spacers. With the rising prevalence of asthma worldwide, retail pharmacies play a crucial role in distributing these essential devices. Their widespread presence in communities, in line with the ease of obtaining prescriptions and guidance from pharmacists, makes retail pharmacies a preferred choice for asthma spacer procurement. As the demand for reliable and accessible asthma management solutions grows, the retail pharmacies segment will maintain its dominant position in the market.

The asthma spacers market share from the volumatic segment will amass considerable gains by 2032 due to the established reputation of volumatic asthma spacers for effectiveness and user-friendliness. Healthcare providers and patients alike prefer the Volumatic spacer for its features like ease of use and compatibility with various inhalers. As the demand for reliable and efficient spacers rises globally, the volumatic segment will maintain its prominence. Its track record of facilitating optimal drug delivery and its widespread adoption in healthcare settings position it as a trusted and sought-after choice, solidifying its pivotal position in the asthma spacers market.

Asia Pacific asthma spacers market will grow at a notable CAGR between 2024 and 2032. This region witnesses a high burden of asthma cases, driven by factors like rising pollution levels and lifestyle changes. With a growing population and increasing healthcare expenditures, there is a heightened demand for effective asthma management solutions. Awareness campaigns and initiatives by healthcare organizations also play a role in boosting the market. As Asia Pacific continues to prioritize respiratory health, its dominance in the asthma spacers industry will persist, making it a primary contributor to market expansion.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of chronic respiratory conditions
  - 3.2.1.2 Technological advancements in the field of asthma spacers
  - 3.2.1.3 Growing awareness regarding the benefits of spacers
  - 3.2.1.4 Rising investment in R&D for product innovation
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of devices
  - 3.2.2.2 Lack of awareness regarding the devices
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Aerochamber
5.3 Optichamber
5.4 Volumatic
5.5 Inspirease
5.6 Other product types

Chapter 6 Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospital pharmacies
6.3 Retail pharmacies
6.4 Online pharmacies

Chapter 7 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 Saudi Arabia
- 7.6.2 South Africa
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa